Share chart Torrent Pharmaceuticals Limited
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited занимается исследованиями, разработкой, производством и маркетингом непатентованных фармацевтических препаратов в Индии, США, Германии, Бразилии и за рубежом. Он предлагает продукты в различных терапевтических областях, включая сердечно-сосудистые, центральную нервную систему, желудочно-кишечный тракт, женское здоровье, диабетологию, обезболивание, гинекологию, онкологию и противоинфекционные средства, а также содержит витамины, минералы и питательные вещества. Компания также предоставляет услуги контрактного производства. more detailsMain settings
ISIN
INE685A01028
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
1.65
Дивиденд ао
32
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 8.17 | 1 |
| P/BV | 12.64 | 1 |
| P/E | 52.3 | 3 |
Efficiency
| Title | Value | Grade |
| ROA | 11.02 | 4 |
| ROE | 25.38 | 8 |
| ROIC | 19.54 | 6 |
Dividends
| Title | Value | Grade |
| Dividend yield | 1.47 | 3.68 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | 20.3 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 1.15 | 8 |
| Debt/Ratio | 0.2671 | 10 |
| Debt/Equity | 1.2 | 8 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 36.32 | 5 |
| Yield Ebitda, % | 54.71 | 7 |
| Yield EPS, % | -19.11 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 3 187.4 ₹ | 0 ₹ | 0 ₹ | -0.93 % | 0 % | 0 % |
| Week | 3 241.5 ₹ | 0 ₹ | 0 ₹ | -2.59 % | 0 % | 0 % |
| Month | 3 238.9 ₹ | 3 157.7 ₹ | 3 302.8 ₹ | -2.51 % | 0 % | 0 % |
| Three month | 3 031.05 ₹ | 3 056.05 ₹ | 3 335 ₹ | 4.18 % | 0 % | 0 % |
| Half a year | 3 224.45 ₹ | 2 930.3 ₹ | 3 469.15 ₹ | -2.07 % | 0 % | 0 % |
| Year | 2 655.25 ₹ | 2 771.7 ₹ | 3 557.25 ₹ | 18.92 % | 0 % | 0 % |
| 3 years | 1 416.3 ₹ | 1 378.95 ₹ | 3 557.25 ₹ | 122.95 % | 0 % | 0 % |
| 5 years | 1 240.32 ₹ | 1 145.6 ₹ | 3 557.25 ₹ | 154.59 % | 0 % | 0 % |
| 10 years | 0 ₹ | 582.78 ₹ | 3 557.25 ₹ | 0 % | 0 % | 0 % |
| Year to date | 3 376.7 ₹ | 2 930.3 ₹ | 3 441.55 ₹ | -6.49 % | 0 % | 0 % |
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF | 0.10495 | 3.13 | 0.20 |
| 0.1 | 3.13 | 0.2 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Sudhir Menon CA, CWA | Chief Financial Officer | 16.3M | 1972 (53 years) |
| Mr. Abdullah Salam Said Al Abri | Chief Customer Service Officer | N/A | |
| Mr. Samir Uttamlal Mehta B.Com., MBA | Executive Chairman & MD | 230.04M | 1964 (61 year) |
| Mr. Aman Mehta | Whole-Time Director | 20.59M | |
| Mr. Chintan M. Trivedi | Company Secretary & Compliance Officer | ||
| Mr. Ashish Hajarnish M.Pharm | Executive Director | 1968 (57 years) | |
| Mr. Jaydip Bhatt | Vice President of Human Resource | 1953 (72 years) |
About company
Address: India, Ahmedabad, Torrent House - Open in google maps, Open in yandex maps
Website: https://www.torrentpharma.com
Website: https://www.torrentpharma.com
